What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Nils Brünner spends much of his time researching Internal medicine, Cancer, Pathology, Breast cancer and Endocrinology.
Nils Brünner has included themes like Gastroenterology and Oncology in his Internal medicine study.
The study incorporates disciplines such as Hematology, Immunology and Enzyme inhibitor in addition to Cancer.
The concepts of his Pathology study are interwoven with issues in Cancer cell, Prognostic variable and Survival analysis.
His study in Breast cancer is interdisciplinary in nature, drawing from both Malignancy, Metastasis, Chemotherapy and Cancer biomarkers.
His Endocrinology research incorporates elements of Receptor, Progesterone receptor, Estrogen receptor and Cell growth.
His most cited work include:
- Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization (635 citations)
- Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. (517 citations)
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers (444 citations)
What are the main themes of his work throughout his whole career to date?
Nils Brünner focuses on Internal medicine, Cancer, Oncology, Breast cancer and Colorectal cancer.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Pathology.
His study looks at the relationship between Endocrinology and fields such as Estrogen receptor, as well as how they intersect with chemical problems.
His studies in Cancer integrate themes in fields like Molecular biology, Cancer research and Blood plasma.
His research integrates issues of Matrix metalloproteinase, Primary tumor, Disease and Hazard ratio in his study of Oncology.
His Colorectal cancer study incorporates themes from Stage, Carcinoembryonic antigen and Bioinformatics.
He most often published in these fields:
- Internal medicine (54.58%)
- Cancer (37.85%)
- Oncology (29.68%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (54.58%)
- Colorectal cancer (26.29%)
- Cancer (37.85%)
In recent papers he was focusing on the following fields of study:
Nils Brünner mainly focuses on Internal medicine, Colorectal cancer, Cancer, Oncology and Cancer research.
His research links Gastroenterology with Internal medicine.
His Colorectal cancer research includes elements of Prospective cohort study, Phases of clinical research and Bioinformatics.
His Cancer research is multidisciplinary, incorporating perspectives in Drug resistance and Pathology.
In his research, Cetuximab is intimately related to KRAS, which falls under the overarching field of Oncology.
His Cancer research study also includes
- Cancer cell which is related to area like Multiple drug resistance,
- Cell together with Glioma.
Between 2013 and 2021, his most popular works were:
- Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer (364 citations)
- Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance (116 citations)
- lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells. (62 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Cancer research, Cancer, Colorectal cancer, Breast cancer and Internal medicine.
His work carried out in the field of Cancer research brings together such families of science as Cell, Copy-number variation, Pathology, Gene and Immunofluorescence.
His Cancer research is multidisciplinary, incorporating elements of Immunohistochemistry, Protein kinase B, PI3K/AKT/mTOR pathway and CD44.
His work deals with themes such as Prospective cohort study, Bioinformatics and Confidence interval, which intersect with Colorectal cancer.
His research integrates issues of Mutation, Epithelial–mesenchymal transition, microRNA and Docetaxel in his study of Breast cancer.
Nils Brünner interconnects Gastroenterology, Surgery, Oncology and Genetic marker in the investigation of issues within Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
